Amanta Healthcare Limited (NSE:AMANTA)

Market Cap	3.44B
Revenue (ttm)	2.76B
Net Income (ttm)	133.20M
Shares Out	34.34M
EPS (ttm)	4.25
PE Ratio	23.56
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,963
Average Volume	75,490
Open	101.98
Previous Close	100.62
Day's Range	100.11 - 105.58
52-Week Range	97.75 - 154.40
Beta	n/a
RSI	38.16
Earnings Date	Feb 10, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 522
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMANTA

Financial Performance

In 2024, Amanta Healthcare's revenue was 2.75 billion, a decrease of -2.01% compared to the previous year's 2.80 billion. Earnings were 105.01 million, an increase of 189.02%.